Skip to main content

and
  1. No Access

    Article

    Traitements médicamenteux des métastases cérébrales des cancers du sein HER2+

    Breast cancer is the second leading cause of brain metastases. In patients with HER2-positive breast cancer, the incidence of brainmetastases is 40%. Although the arrival of anti-HER2 therapies has meant bette...

    P. Heudel, O. Tredan, P. Cassier, I. Ray-Coquard, J. -P. Guastalla in Oncologie (2012)